Kjetil Hestdal • 1960 • Oslo • 6 roles • 12 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
C CAEDO ONCOLOGY AS	Managing Director/CEO	-	14,416,685	6.94 % indirectly
S SERCA PHARMACEUTICALS AS	Managing Director/CEO	3,571,688	16,391,412	1.51 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
K K OG K AS	Chairman	5,524,443	22,477,695	50 % directly
A AUGERE MEDICAL AS	Board Member	761,740	14,822,199	1.02 % indirectly
L LYTIX BIOPHARMA AS	Board Member	3,991,213	51,319,307	-
N NILSESTØLVEGEN VEILAG	Board Member	-	-	-

Last update: Aug 1, 2024

Related industries3

Professional, scientific and technical activities
Real estate activities
Wholesale and retail trade; repair of motor vehicles and motorcycles

Direct relationships5

EP
Erlend Petter Skagseth1955
SERCA PHARMACEUTICALS AS, CAEDO ONCOLOGY AS
BK
Brynjar Kristian Forbergskog1958
LYTIX BIOPHARMA AS
OJ
Ole Jesper Dahlberg1971
CAEDO ONCOLOGY AS
KE
Knut Einar Haug1964
NILSESTØLVEGEN VEILAG
KS
Kristin Sandereid1968
SERCA PHARMACEUTICALS AS

Shares owned by Kjetil Hestdal

Name	Share class	Total operating income	Total equity	Share
K K OG K AS	Ordinære aksjer	5,524,443	22,477,695	50 % directly
C CAEDO ONCOLOGY AS		0	14,416,685	6.94 % indirectly
S SERCA PHARMACEUTICALS AS		3,571,688	16,391,412	1.51 % indirectly
A AUGERE MEDICAL AS		761,740	14,822,199	1.02 % indirectly
N NOWWELL AS		4,746,705	5,686,904	0.54 % indirectly
N NOWWELL FLOW TECHNOLOGY AS		244,148	-1,058,712	0.54 % indirectly
N NOWWELL DEVELOPMENT AS		-	-	0.54 % indirectly
N NOWWELL HOLDING AS		-	-	0.54 % indirectly
N NOWWELL SOLUTION AS		-	-	0.54 % indirectly
H HAGA GOLF AS	NO0010118144	30,490,168	58,516,828	0.06 % directly < 0.01 %
V VISTIN PHARMA ASA	NO0010734122	0	265,148,000	< 0.01 % directly
M MEDISTIM ASA	NO0010159684	341,024,000	214,848,000	< 0.01 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024